Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05224986

Lifestyle Patterns and Glycemic Control

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
25 Years
Healthy volunteers
Not accepted

Summary

The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes. The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.

Detailed description

Variability in lifestyle behaviors has been associated with adverse health, specifically poor glucose control. The project proposes to test whether reducing this variability improves glycemia in patients with pre-diabetes. If successful, this simple positive lifestyle message to keep stable behaviors has the potential to improve the health of millions of adults worldwide. This project will enroll participants with pre-diabetes who have erratic lifestyle behaviors and randomize them to either maintain their usual habits (control group) or stabilize their behaviors (stability group). Both groups will be followed for 12 weeks. Before the start of the 12-week period, all participants will track their sleep for 2 weeks and will wear a glucose monitor to measure their glucose levels. At the start and end of the 12-week period, they will come to the research lab to undergo a glucose tolerance test. This test will measure how their body reacts to a glucose load. They will also undergo magnetic resonance imaging and spectroscopy scanning. This scan will provide information on body composition and liver fat content.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFixed ScheduleParticipants will be asked to maintain a fixed schedule for 12 weeks.

Timeline

Start date
2022-01-19
Primary completion
2026-06-30
Completion
2026-07-31
First posted
2022-02-04
Last updated
2026-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05224986. Inclusion in this directory is not an endorsement.